Evidence map›Paper›PMID 24039906›Full record

ArticlePloS one2013

Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations.

Hideo Yonezawa, Takako Osaki, Tomoko Hanawa, Satoshi Kurata, Kuniyasu Ochiai, Shigeru Kamiya

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Nanomaterials: A Prospective Strategy for Biofilm-FormingInternational journal of nanomedicine · 2025
    Review
  8. International journal of molecular sciences · 2024
    Review
  9. Molecular Mechanisms of Biofilm Formation inAntibiotics (Basel, Switzerland) · 2024
    Review
  10. Opportunities forMicroorganisms · 2024
    Review
  11. Article
  12. Molecular tools of antibiotic resistance forFrontiers in gastroenterology (Lausanne, Switzerland) · 2024
    Review
  13. Biofilm and Cancer: Interactions and Future Directions for Cancer Therapy.International journal of molecular sciences · 2023
    Review
  14. Article
  15. Discovery of Novel Resistance Mechanisms ofAntibiotics (Basel, Switzerland) · 2023
    Article
  16. Article
  17. Multi-functional vesicles improveActa pharmaceutica Sinica. B · 2022
    Article
  18. Article
  19. Infection and drug resistance · 2022
    Review
  20. Prevalence of antibiotic resistance ofAmerican journal of translational research · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hideo YonezawaDepartment of Infectious Diseases, Kyorin University School of Medicine, Tokyo, Japan.
Takako Osaki
Tomoko Hanawa
Satoshi Kurata
Kuniyasu Ochiai
Shigeru Kamiya
Kyorin University · JPNihon University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human gastric pathogen Helicobacter pylori forms biofilms in vitro and in vivo. The purpose of this study was to evaluate the effects of H. pylori biofilm formation in vitro on clarithromycin (CLR) susceptibility. CLR susceptibility of H. pylori intermediate (2-day) and mature (3-day) biofilms on glass coverslips was determined at concentrations from 0.03 to 0.5 µg/ml. H. pylori biofilm biomass was increased after treatment with CLR at minimum inhibitory concentration levels by up to 4-fold (2-day biofilm) and 16-fold (3-day biofilm). Minimum bactericidal concentrations of CLR against cells in a biofilm were higher (1.0 µg/ml) than that for planktonic cells (0.25 µg/ml). It was shown that the expression of efflux pump genes was significantly increased in biofilm cells. In addition, exposure of biofilms to CLR resulted in high level resistance generation compared to planktonic cells with increased resistance associated with the presence of a point mutation at either position 2142 or 2143 in the domain V loop of the 23S rRNA gene. These results demonstrate that H. pylori biofilm formation decreases the susceptibility to CLR and that H. pylori CLR resistance mutations are more frequently generated in biofilms than in planktonic cells.

Indexed as

Anti-Bacterial AgentsBiofilmsClarithromycinDrug Resistance, BacterialHelicobacter InfectionsHelicobacter pyloriHumansMutationRNA, Ribosomal, 23SAnti-Bacterial AgentsClarithromycinRNA, Ribosomal, 23S

Identifiers

PMID24039906
PMCPMC3765302
OpenAlexW1981915387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.